Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
231901-2021 - Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States
United Kingdom-London: Diagnostic supplies
Contract award notice
Results of the procurement procedure
Section I: Contracting authority
Section II: Object
Provision of Innova SARS-CoV-2 Antigen Rapid Qualitative Test Kits
Provision of lateral flow antigen test kits and associated consumables, to support the UK Covid-19 testing strategy.
Contract for lateral flow kits and consumables.
Section IV: Procedure
Negotiated procedure without prior publication
1) The Covid-19 outbreak is a public health emergency of international concern as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised Covid-19 as a pandemic on 11 March 2020.
2) A key element of ensuring an effective response to the pandemic is ensuring that there is adequate testing. Therefore, the provision of test kits is critical to this response.
3) DHSC is satisfied with the tests permitting use of the negotiated procedure without prior publication (Regulation 32(2)(c)) are met:
A. As far as is strictly necessary: The Lateral Flow Tests were identified as strictly necessary to meet the demand to scale up the mass testing programme in the UK.
B. There are genuine reasons for extreme urgency: there is a surge in global demand for lateral flow tests. DHSC is responding to Covid-19 immediately because of public health risks presenting a genuine emergency.
C. The events that have led to the need for extreme urgency were unforeseeable: the timing of availability of new Covid-19 Lateral Flow Test technology meeting the relevant UK technical requirements coupled with high international demand and limited global capacity was not foreseeable.
D. It is impossible to comply with the usual timescales in the PCR: it is not possible to comply with the timescales of another procedure due to the urgent requirement to ensure the delivery of the Lateral Flow Tests for distribution across the UK.
E. The situation is not attributable to the contracting authority – DHSC has not done anything to cause or contribute to the need for extreme urgency.
Section V: Award of contract
Section VI: Complementary information
INNOVA are providing Lateral flow test kits to support the UK Covid-19 testing strategy and to enable mass testing for C-19 through rapid testing and to supplement diagnostics capacity.